Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial.
作者信息
Rahmanzadeh Reza, Eftekhari Sanaz, Shahbazi Ali, Khodaei Ardakani Mohammad-Reza, Rahmanzade Ramin, Mehrabi Soraya, Barati Mahmood, Joghataei Mohammad Taghi
机构信息
Division of Neuroscience, Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Faculty of Advanced Technologies in Medicine, Department of Neuroscience, Iran University of Medical Sciences, Tehran, Iran.
出版信息
Schizophr Res. 2017 Jun;184:145-146. doi: 10.1016/j.schres.2016.12.002. Epub 2016 Dec 9.
PMID:27956008
Abstract
摘要
Zotero 插件